Skip to main content
PCI Biotech Holding logo

PCI Biotech Holding — Investor Relations & Filings

Ticker · PCIB ISIN · NO0010405640 LEI · 5967007LIEEXZXFIGG77 OL Manufacturing
Open in API
Filings indexed 752 across all filing types
Latest filing 2017-05-08 AGM Information
Country NO Norway
Listing OL PCIB

About PCI Biotech Holding

https://www.pcibiotech.no/

PCI Biotech Holding is a biopharmaceutical company developing therapeutic products based on its proprietary Photochemical Internalization (PCI) technology. This platform is a drug and nucleic acid delivery system designed to enhance the intracellular delivery of therapeutic molecules. The company's development programs are focused on applications in immunotherapy, dermatology, and bioprocessing for the manufacturing of viral vectors. A primary therapeutic area for the technology is cancer, where it aims to improve the efficacy of novel and existing treatments.

Recent filings

Filing Released Lang Actions
PCI Biotech: Notice of Annual General Meeting 2017
AGM Information Classification · 99% confidence The document text explicitly contains the Norwegian phrase "INNKALLING TIL ORDINÆR GENERALFORSAMLING" and the English translation "NOTICE OF ORDINARY GENERAL MEETING". It details the time, place, and agenda for a shareholder meeting, including items like electing the board and approving remuneration. This content is characteristic of a formal notice convening an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM-R.
2017-05-08 English
PCI Biotech: Notice of Annual General Meeting 2017
Board/Management Information Classification · 98% confidence The document is a formal proposal ('Innstilling') from the Nomination Committee ('Valgkomitéen') of PCI Biotech Holding ASA, dated May 4, 2017. It details the proposed composition of the Board of Directors ('Styresammensetning') for re-election and proposes remuneration ('Honorar til styret'). This content directly relates to the composition and election of the board and management structure, which aligns perfectly with the 'Board/Management Information' category.
2017-05-08 English
PCI Biotech: Notice of Annual General Meeting 2017
Remuneration Information Classification · 98% confidence The document is titled 'Styrets erklæring om fastsettelse av lønn og annen godtgjørelse for ledende ansatte' (Statutory declaration on salary and other remuneration to senior management) and explicitly states it is prepared in accordance with the Norwegian Public Limited Liability Companies Act Section 6-16a and presented to the general meeting. It details policies regarding salary, bonus, options, pension, and severance for senior management. This content directly corresponds to the definition of Remuneration Information (DEF 14A), which covers compensation for top executives and directors, often presented as a standalone statement or part of proxy materials.
2017-05-08 English
PCI Biotech: Notice of Annual General Meeting 2017
AGM Information Classification · 98% confidence The document is explicitly titled 'PCI Biotech: Notice of Annual General Meeting 2017' and invites shareholders to attend the AGM scheduled for May 29, 2017. It mentions attached documents like the 'Notice of Annual General Meeting including attendance and proxy forms' and the 'executive remuneration statement'. Since the document is a formal notice and invitation to the Annual General Meeting, it directly corresponds to the AGM Information category.
2017-05-08 English
PCI Biotech: Invitation to first quarter 2017 presentation
Report Publication Announcement Classification · 98% confidence The document is very short (1281 characters) and explicitly serves as an 'Invitation to first quarter 2017 presentation'. It announces the time, location, and webcast details for the presentation of the 'first quarter 2017 report'. Crucially, it states that the interim report and the presentation will be available later on specific websites. According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement about the publication of a report, rather than the report itself, should be classified as a Report Publication Announcement (RPA). The content is an announcement about the release of an interim report (which would typically be an IR), but the document itself is the invitation/announcement of that release.
2017-05-05 English
PCI Biotech: Employee share option scheme
Remuneration Information Classification · 99% confidence The document announces the award of share options to key employees, including the CEO, CSO, and CFO, detailing the number of options, strike price, vesting schedule, and resulting insider holdings. This activity directly relates to the compensation and equity structure involving directors and executives. While it involves share transactions, it is specifically about the granting of options rather than the company buying back its own shares (POS) or a formal remuneration report (DEF 14A). Since it details transactions by directors/executives (insider dealing/equity grants), it most closely aligns with Director's Dealing (DIRS) or a specific type of Capital/Financing Update (CAP). Given the focus on executive equity grants and resulting insider holdings, DIRS is a strong candidate, but the core action is the issuance of options as part of compensation. However, looking at the definitions, 'Director's Dealing (DIRS)' covers 'Report of personal share transactions by company directors and executives (insider trades)'. The grant of options is a form of executive compensation/insider transaction. If the options were being exercised or sold, DIRS would be definitive. Since this is an award/grant, it is a form of capital/financing activity related to employee incentives. Given the options are granted to key employees and detail their resulting holdings, it fits best under the umbrella of insider transactions/executive equity, making DIRS the most appropriate fit among the specific codes, as it details transactions/holdings of key personnel. Alternatively, it could be seen as a Capital/Financing Update (CAP) as it changes the outstanding option pool, but DIRS focuses on the personnel aspect which is heavily detailed here.
2017-05-05 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.